Clive Drakeford

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis.

Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Alimentary pharmacology & therapeutics
Published: June 19, 2025

Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria.

Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria.

Journal: Haematologica
Published: December 02, 2021

von Willebrand factor links primary hemostasis to innate immunity.

von Willebrand factor links primary hemostasis to innate immunity.

Journal: Nature communications
Published: July 24, 2020

Physician, heal thyself: a cross-sectional survey of doctors' personal prescribing habits.

Physician, heal thyself: a cross-sectional survey of doctors' personal prescribing habits.

Journal: Journal of medical ethics
Published: July 17, 2018

Targeting von Willebrand Factor-Mediated Inflammation.

Targeting von Willebrand Factor-Mediated Inflammation.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 25, 2017

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.

Journal: Blood
Published: June 06, 2017

Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.

Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 28, 2016

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.

Journal: BMC cancer
Published: April 22, 2016

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.

Journal: Blood
Published: April 16, 2016

Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.

Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.

Journal: Blood
Published: March 06, 2015

Engineering activated protein C to maximize therapeutic efficacy.

Engineering activated protein C to maximize therapeutic efficacy.

Journal: Biochemical Society transactions
Published: December 12, 2014

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer.

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer.

Journal: Biochimica et biophysica acta
Published: August 01, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026